Latest filings (excl ownership)
REVOKED
Registration or securities revoked
16 Jul 14
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
4 Mar 13
8-K
Entry into a Material Definitive Agreement
24 Oct 12
8-K
SCOLR Pharma Announces Unaudited Net Sales of Nutritional Products
28 Jun 12
8-K
Entry into a Material Definitive Agreement
15 Jun 12
D
$1.35M in debt / options, sold $308K, 7 investors
18 May 12
8-K
Entry into a Material Definitive Agreement
10 May 12
8-K
Departure of Directors or Certain Officers
5 Apr 12
NT 10-K
Notice of late annual filing
30 Mar 12
8-K
Entry into a Material Definitive Agreement
26 Mar 12
8-K
Entry into a Material Definitive Agreement
14 Feb 12
8-K
Entry into a Material Definitive Agreement
8 Feb 12
10-Q
2011 Q3
Quarterly report
10 Nov 11
8-K
SCOLR Pharma, Inc. Announces Third Quarter 2011 Financial Results
10 Nov 11
CT ORDER
Confidential treatment order
30 Aug 11
10-Q
2011 Q2
Quarterly report
26 Jul 11
8-K
SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results
26 Jul 11
8-K
SCOLR Pharma, Inc. Announces Final Closing of Private Placement
7 Jul 11
D/A
$1.2M in debt / options, sold $1.2M, 82 investors
30 Jun 11
D
$1.75M in debt / options, sold $1M, 62 investors
23 Jun 11
8-K
SCOLR Pharma, Inc. Announces Initial Closing of Private Placement
16 Jun 11
8-K
Other Events
16 Jun 11
8-K
Amendments to Articles of Incorporation or Bylaws
14 Jun 11
8-K
Entry into a Material Definitive Agreement
7 Jun 11
10-Q
2011 Q1
Quarterly report
9 May 11
8-K
SCOLR Pharma, Inc. First Quarter 2011 Financial Results
9 May 11
DEF 14A
Definitive proxy
28 Apr 11
8-K
Signs New Lease Amendment and Lowers Severance Amounts in Executive Contracts
27 Apr 11
CT ORDER
Confidential treatment order
21 Apr 11
CORRESP
Correspondence with SEC
20 Apr 11
UPLOAD
Letter from SEC
20 Apr 11
UPLOAD
Letter from SEC
19 Apr 11
UPLOAD
Letter from SEC
14 Apr 11
PRE 14A
Preliminary proxy
12 Apr 11
CORRESP
Correspondence with SEC
4 Apr 11
10-K
2010 FY
Annual report
29 Mar 11
8-K
Provides Updates on Advances in Nutritionals, OTC Drugs
29 Mar 11
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
29 Mar 11
EFFECT
Notice of effectiveness
28 Mar 11
EFFECT
Notice of effectiveness
28 Mar 11
Latest ownership filings
No filings